[go: up one dir, main page]

BR9916963A - Bupropiona para tratamento de doenças virais - Google Patents

Bupropiona para tratamento de doenças virais

Info

Publication number
BR9916963A
BR9916963A BR9916963-0A BR9916963A BR9916963A BR 9916963 A BR9916963 A BR 9916963A BR 9916963 A BR9916963 A BR 9916963A BR 9916963 A BR9916963 A BR 9916963A
Authority
BR
Brazil
Prior art keywords
bupropion
treatment
viral diseases
virus
bupropiona
Prior art date
Application number
BR9916963-0A
Other languages
English (en)
Inventor
Christopher Willian Reindler
Original Assignee
Planisphere Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Planisphere Corp filed Critical Planisphere Corp
Publication of BR9916963A publication Critical patent/BR9916963A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"BUPROPIONA PARA TRATAMENTO DE DOENçAS VIRAIS". é revelado um método e composição para o tratamento e prevenção de uma infecção viral num paciente humano ou animal pela administração de bupropiona õu um sal, solvato ou enantiómero fisiologicamente aceitável de bupropiona. Preferivelmente, o vírus é um vírus da família Herpes ou uma condição causada pelo mesmo, principalmente HSV1 ou HSV2.
BR9916963-0A 1998-12-08 1999-12-07 Bupropiona para tratamento de doenças virais BR9916963A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13549498P 1998-12-08 1998-12-08
PCT/AU1999/001089 WO2000033827A1 (en) 1998-12-08 1999-12-07 Bupropion to treat viral diseases

Publications (1)

Publication Number Publication Date
BR9916963A true BR9916963A (pt) 2002-03-05

Family

ID=22468359

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916963-0A BR9916963A (pt) 1998-12-08 1999-12-07 Bupropiona para tratamento de doenças virais

Country Status (14)

Country Link
US (2) US6512011B1 (pt)
EP (1) EP1156791B1 (pt)
JP (1) JP4166955B2 (pt)
AT (1) ATE295159T1 (pt)
AU (1) AU762624B2 (pt)
BR (1) BR9916963A (pt)
CA (1) CA2349487C (pt)
DE (1) DE69925312T2 (pt)
ES (1) ES2242438T3 (pt)
HK (1) HK1042239B (pt)
MX (1) MXPA01005725A (pt)
NZ (1) NZ512716A (pt)
PT (1) PT1156791E (pt)
WO (1) WO2000033827A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030134905A1 (en) * 2002-01-11 2003-07-17 Reindler Christopher William Bupropion to treat viral diseases
DE102004063132A1 (de) * 2004-12-22 2006-07-06 Schmiegel, Wolff, Prof. Dr. Verwendung von Bupropion in Arzneimittel zur Behandlung von Hepatitis C
US7241805B2 (en) 2005-06-27 2007-07-10 Biovail Laboratories, Inc. Modified release formulations of a bupropion salt
SG178345A1 (en) * 2009-08-10 2012-03-29 Biocopea Ltd Treatment of viral infections
GB2477584A (en) * 2010-02-04 2011-08-10 Biocopea Ltd A compound for use in treating an acute viral infection
CN108721262A (zh) * 2017-04-13 2018-11-02 中国科学院武汉病毒研究所 安非他酮在制备治疗或预防流感病毒感染的药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438138A (en) * 1982-12-06 1984-03-20 Burroughs Wellcome Co. Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
US4507323A (en) * 1984-07-25 1985-03-26 Burroughs Wellcome Co. Treatment of psychosexual dysfunctions
US5753712A (en) * 1994-02-18 1998-05-19 Pinsker; Walter Treatment of migraine headaches and formulations
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer

Also Published As

Publication number Publication date
NZ512716A (en) 2003-10-31
JP4166955B2 (ja) 2008-10-15
DE69925312T2 (de) 2006-03-09
JP2002531495A (ja) 2002-09-24
PT1156791E (pt) 2005-08-31
ES2242438T3 (es) 2005-11-01
HK1042239A1 (en) 2002-08-09
DE69925312D1 (de) 2005-06-16
MXPA01005725A (es) 2003-07-14
EP1156791B1 (en) 2005-05-11
CA2349487A1 (en) 2000-06-15
EP1156791A1 (en) 2001-11-28
AU762624B2 (en) 2003-07-03
AU1762900A (en) 2000-06-26
US20020173551A1 (en) 2002-11-21
EP1156791A4 (en) 2002-05-02
CA2349487C (en) 2007-09-11
HK1042239B (en) 2005-12-09
ATE295159T1 (de) 2005-05-15
US6512011B1 (en) 2003-01-28
WO2000033827A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
MY117892A (en) Therapeutic compounds
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
PT668763E (pt) Utilizacao de fenserina para a preparacao de medicamentos para tratar doencas do conhecimento
EP1064000A4 (en) VITAMIN D AND ITS ANALOGS FOR THE TREATMENT OF TUMORS AND OTHER HYPERPROLIFERATION DISORDERS
IL157504A0 (en) Oncolytic virus therapy
CA2503810A1 (en) Therapeutic agent for fibromyalgia
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
DK0501705T3 (da) Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje
ES2136167T3 (es) Composiciones de idebenona para tratar la enfermedad de alzheimer.
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
ZA991749B (en) Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy.
MX9805441A (es) Compuestos terapeuticos.
BR9916963A (pt) Bupropiona para tratamento de doenças virais
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
WO2000016786A3 (en) Oxihumic acid and its use in the treatment of various conditions
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
GR3032224T3 (en) Therapeutic agent for threatened abortion.
DE3872881D1 (de) Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten.
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
Naik et al. 8-Methoxypsoralen-lnduced Nail Pigmentation.
BR0114339A (pt) Composições farmaceuticamente aceitáveis contendo epinastina e pseudoefedrina
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
ZA9410381B (en) Use of Bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases
HU9201295D0 (en) Medical preparations for treating cryptosporidiosys

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: PERDA DA PRIORIDADE REIVINDICADA POR NAO ATENDER A DISPOSICAO PREVISTA NO ART. 16 6O DA LPI.

B12F Other appeals [chapter 12.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A E 12A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.